Seroprevalence of hepatitis b and hepatitis C markers in adolescents in Southern Brazil;Soroprevalëncia de marcadores de hepatite B e hepatite C em adolescentes no Sul do Brasil

Cadernos de Saude Publica

Volumn 27, Issue 4, 2011, Pages 753-758

  Scaraveli, Natália Gazzoni ^a   Passos, Ana Maria ^a   Voigt, Andréia Royer ^a   do Livramento, Andréa ^a   Tonial, Gabriela ^a   Treitinger, Aricio ^a   Spada, Celso ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Hepatitis B; Hepatitis C; Seroepidemiologic studies; Vaccination

Indexed keywords

BIOLOGICAL MARKER; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN M;

ADOLESCENT; ARTICLE; BLOOD; BRAZIL; CHILD; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOLOGY; MALE; PREVALENCE;

ADOLESCENT; BIOLOGICAL MARKERS; BRAZIL; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOGLOBULIN M; MALE; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES;

EID: 79957650797     PISSN: 0102311X     EISSN: 16784464     Source Type: Journal    
DOI: 10.1590/S0102-311X2011000400014     Document Type: Article

References (38)

1. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006; 45:529-538.
2. World Health Organization. Hepatitis B. http://www.who.int/immunization_delivery/new_vaccines/hepb/en/index.html (accessed on Jul/2009).
3. World Health Organization. Programmes and projects. Fact sheet no. 164 - Hepatitis C. http://www.who.int/mediacentre/factsheets/fs164/en/ (accessedon Jul/2009).
4. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics. CA Cancer J Clin 2002; 55:74-108.
5. World Health Organization. Global distribution of hepatitis A, B and C, 2001. Wkly Epidemiol Rec 2002; 77:45-47.
6. Brandão AB, Fuchs SC. Risk factors for hepatitis C virus infection among blood donors in southern Brazil: a case control study. BMC Gastroenterol 2002; 2:18.
7. Rosini N, Mousse D, Spada C, Treitinger A. Seroprevalence of HbsAg, Anti-HBc and Anti-HCV in Southern Brazil, 1999-2001. Braz J Infect Dis 2003; 7:262-267.
8. Andrade AFB, Oliveira-Silva M, Silva SGC, Motta IJF, Bonvicino CR. Seroprevalence of hepatitis B and C virus markers among blood donors in Rio de Janeiro, Brazil, 1998-2005. Mem Inst Oswaldo Cruz 2006; 101:673-676.
9. Nascimento MC, Mayaud P, Sabino EC, Torres KL, Franceschi S. Prevalence of hepatitis B and C serological markers among first-time blood donors in Brazil: a multi-center serosurvey. J Med Virol 2008; 80:53-57.
10. Kupski C, Träsel FR, Mazzoleni F, Winckler MA, Bender AL, Machado DC, et al. Serologic and molecular profile of anti-HBc-positive blood bank donors in an area of low endemicity for HBV. Dig Dis Sci 2008; 53:1370-1374.
11. Torres KL, Malheiro A, Tateno A, Lima TA, Viana- Maia LP, Diniz-Pimentel JP, et al. Hepatitis C virus in blood donors, Brazil. Emerg Infect Dis 2009; 15:676-678.
12. Garcia FB, Pereira GA, Martins PRJ, Moraes-Souza H. Epidemiological profile of hepatitis C in blood donors at the Uberaba Regional Blood Center. Rev Soc Bras Med Trop 2009; 42:1-4.
13. Miranda AE, Figueiredo NC, Schmidt R, Page-Shafer K. A population-based survey of the prevalence of HIV, syphilis, hepatitis B and hepatitis C infections, and associated risk factors among young women in Vitória, Brazil. AIDS Behav 2008; 12(4 Suppl):S25-31.
14. Aquino JA, Pegado KA, Barros LP, Machado LFA. Soroprevalência de infecções por vírus da hepatite B e vírus da hepatite C em indivíduos do Estado do Pará. Rev Soc Bras Med Trop 2008; 41:334-337.
15. Ferrão SBRL, Figueiredo JFC, Yoshida CFT, Passos ADC. Prevalência elevada de hepatite C no distrito de Botafogo, cidade de Bebedouro, interior do Estado de São Paulo, Brasil, 2007. Cad Saúde Pública 2009; 25:460-464.
16. Toledo Júnior AC, Greco DB, Felga M, Barreira D, Gadelha MFS, Speranza FAB. Seroprevalence of hepatitis B and C in Brazilian army conscripts in 2002: a cross-sectional study. Braz J Infect Dis 2005; 9:374-383.
17. Treitinger A, Spada C, Ferreira LA, Strazer Neto MS, Reis M, Verdi JC, et al. Hepatitis B and hepatitis C prevalence among blood donors and HIV-1 infected patients in Florianópolis, Brazil. Braz J Infect Dis 2000; 4:192-196.
18. Secretaria de Vigilância em Saúde, Ministério da Saúde. Material instrucional para capacitação em vigilância epidemiológica das hepatites virais. Brasília: Ministério da Saúde; 2008. (Série A. Normas e Manuais Técnicos).
19. Centers for Disease Control and Prevention. Viral hepatitis. http://www.cdc.gov/hepatitis/index.htm (accessed on Jul/2009).
20. Meheus A. Teenager's lifestyle and the risk of exposure to hepatitis B virus. Vaccine 2000; 18:26-29.
21. Motta VT, Wagner MB. Bioestatística. Caxias do Sul: Educs/São Paulo: Robe Editorial; 2003.
22. Centers for Disease Control. Recommendations for protection against viral hepatitis. MMWR Morb Mortal Wkly Rep 1985; 34:313-324.
23. Centers for Disease Control. Update on hepatitis B prevention. MMWR Morb Mortal Wkly Rep 1987; 36:353-360.
24. Immunization against hepatitis B. Lancet 1988; 1:875-876.
25. Bertolini DA, Pinho JRR, Saraceni CP, Moreira RC, Granato CFH, Carrilho FJ. Prevalence of serological markers of hepatitis B virus in pregnant women from Paraná State, Brazil. Braz J Med Biol Res 2006; 39:1083-1090.
26. Jafri W, Jafri N, Yakoob J, Islam M, Tirmizi SFA, Jafar T, et al. Hepatitis B and C: prevalence and risk factors associated with seropositivity among children in Karachi, Pakistan. BMC Infect Dis 2006; 6:101.
27. Chongsrisawat V, Yoocharoen P, Theamboonlers A, Tharmaphornpilas P, Warinsathien P, Sinlaparatsamee S, et al. Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the national expanded programme on immunization. Trop Med Int Health 2006; 11:1496-502.
28. Souto FJD. Distribuição da hepatite B no Brasil: atualização do mapa epidemiológico e proposições para seu controle. GED Gastroenterol Endosc Dig 1999; 18:143-150.
29. Zanetti AR, Mariano A, Romanò L, D'Amelio R, Chironna M, Coppola RC, et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 2005; 366:1379-1384.
30. Fitzsimons D, François G, Hall A, McMahon B, Meheus A, Zanetti A, et al. Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants. Vaccine 2005; 23: 4158-4166.
31. Hammitt LL, Hennessy TW, Fiore AE, Zanis C, Hummel KB, Dunaway E, et al. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years. Vaccine 2007; 25:6958-6964.
32. But DY, Lai CL, Lim WL, Fung J, Wong DK, Yuen MF. Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: final report. Vaccine 2008; 26:6587-6591.
33. Banatvala JE, van Damme P. Hepatitis B vaccine -do we need boosters? J Viral Hepat 2003; 10:1-6.
34. Vogt M, Lang T, Frösner G, Klingler C, Sendl AF, Zeller A, et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med 1999; 341:866-870.
35. Gerner P, Wirth S, Wintermeyer P, Walz A, Jenke A. Prevalence of hepatitis C virus infection in children admitted to an urban hospital. J Infect 2006; 52:305-308.
36. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341:556-562.
37. Idrees M, Lal A, Naseem M, Khalid M. High prevalence of hepatitis C virus infection in the largest province of Pakistan. J Dig Dis 2008; 9:95-103.
38. Riestra S, Fernández E, Leiva P, García S, Ocio G, Rodrigo L. Prevalence of hepatitis C virus infection in the general population of northern Spain. Eur J Gastroenterol Hepatol 2001; 13:477-481.